Frank Hsu
Director/Board Member at Karin Grunebaum Cancer Research Foundation
Frank Hsu active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Karin Grunebaum Cancer Research Foundation | Director/Board Member | - | - |
Career history of Frank Hsu
Former positions of Frank Hsu
| Companies | Position | Start | End |
|---|---|---|---|
| APEXIGEN, INC. | Chief Tech/Sci/R&D Officer | - | 2023-08-22 |
| Sales & Marketing | - | - | |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 2013-09-30 | 2017-12-31 |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2012-05-31 | 2013-05-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2001-12-31 | 2011-12-31 |
Yale Cancer Center
 Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 1995-12-31 | 2001-12-31 |
| Stanford University | Corporate Officer/Principal | 1995-12-31 | 1995-12-31 |
| ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-08-25 | - |
Training of Frank Hsu
| Stanford University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistics
International
| United States | 10 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| APEXIGEN, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Zyngenia, Inc.
Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Retail Trade |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Yale Cancer Center operates as a cancer center. It offers cancer immunology, cancer prevention and control, developmental therapeutics, genomics, genetics and epigenetics, radiobiology and radiotherapy, signal transduction, virus and other infection-associated cancers programs. The company was founded in 1974 and is headquartered in New Haven, CT. | Health Services |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
| Karin Grunebaum Cancer Research Foundation |
- Stock Market
- Insiders
- Frank Hsu
- Experience
